FDA releases the form FDA-483 with six observations from an inspection at the Baxter Oncology drug manufacturing facility in Halle, Westfalen, Germany.
FDA publishes 76 new and revised product-specific guidances intended to speed generic drug development and approval.
FDA releases the form FDA-483 with six observations from an inspection at the Baxter Oncology drug manufacturing facility in Halle, Westfalen, Germany.
FDA publishes 76 new and revised product-specific guidances intended to speed generic drug development and approval.
The Trump Administration announces new agreements with Eli Lilly and Novo Nordisk to lower U.S. prices for several products, including the GLP-1 medications Ozempic and Wegovy.
FDA announces six additional drugs awarded Commissioner’s National Priority vouchers.
